severe infection Clinical Trials

9 recruitingLast updated: June 20, 2026

There are 9 actively recruiting severe infection clinical trials across 4 countries. Studies span Phase 4. Top locations include Créteil, France, Lyon, France, Changsha, Hunan, China. Updated daily from ClinicalTrials.gov.


severe infection Trials at a Glance

9 actively recruiting trials for severe infection are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 4 with 1 trial, with the heaviest enrollment activity in Créteil, Lyon, and Changsha. Lead sponsors running severe infection studies include Association Clinique Thérapeutique Infantile du val de Marne, Hospices Civils de Lyon, and Children's Hospital of Fudan University.

Browse severe infection trials by phase

About severe infection Clinical Trials

Looking for clinical trials for severe infection? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new severe infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about severe infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

severe infectionMyeloma, MultipleCMV Reactivation+3 more
Infanta Leonor University Hospital350 enrolled2 locationsNCT07609576
Recruiting

CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit

severe infectionHospitalized ChildrenInvasive Bacterial Infection
Association Clinique Thérapeutique Infantile du val de Marne3,000 enrolled1 locationNCT06260345
Recruiting

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

severe infection
Children's Hospital of Fudan University2,000 enrolled1 locationNCT04923828
Recruiting

Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit

severe infectionSevere Immune Deficiency
University Hospital, Montpellier100 enrolled1 locationNCT04990908
Recruiting

Invasive Group A Streptococcal Infection

severe infectionMedical CareRisk Factors+6 more
Association Clinique Thérapeutique Infantile du val de Marne100 enrolled1 locationNCT05788861
Recruiting

PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

severe infection
Hospices Civils de Lyon250 enrolled1 locationNCT06185920
Recruiting
Phase 4

Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model

severe infection
Central South University112 enrolled1 locationNCT06161870
Recruiting

Phage Safety Cohort Study

severe infectionProsthetic joint infection
Hospices Civils de Lyon100 enrolled1 locationNCT04650607
Recruiting

The IMPROVE trial: IMpact of PRObiotic interVEntion in Papua New Guinean newborns.

Clinical severe infection
Telethon Kids Institute195 enrolled1 locationACTRN12620001369910